LABD Direxion Daily S&P Biotech Bear 3X ETF
AMEXETFAs of 2026-08-28 16:00
Why LABD matters now
Direxion Daily S&P Biotech Bear 3X ETF (LABD) is a US etf in Financial Services. The latest InvestLog snapshot shows $6.61 with +10.54% on the session and $15.1M in assets/market value.
ETF Profile
Updated 2026-08-29Net Assets
$76.7M
NAV
$5.99
Expense Ratio
1.08%
Holdings
11
Issuer
Direxion
Asset Class
Leveraged/Inverse
Avg Volume
10,156,641
Inception
2015-05-28
Sector Exposure
Top Holdings
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| — | SPSIBI SWAP ASSET LEG | 170.40% | $-230.1M |
| — | DREYFUS TRSRY SECURITIES CASH MGMT | -3.27% | $4.4M |
| — | GOLDMAN SACHS FIN GOV 465 INSTITUT | -15.69% | $21.2M |
| — | DREYFUS GOVT CASH MAN INS | -20.96% | $28.3M |
| — | GOLDMAN FINL SQ TRSRY INST 506 | -30.50% | $41.2M |
Fund Info
Asset Type
ETF
Exchange
AMEX
Currency
USD
Issuer
Direxion
Asset Class
Leveraged/Inverse
NAV Currency
USD
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.